布鲁氏菌M5-90疫苗株virB2基因缺失株的构建及鉴定
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家“973”计划项目(2010CB30203);国际科技合作项目(2006DFA33740);国家自然科学基金项目(30760187);国家自然科学基金项目(30800813)


Construction and identification of virB2 deletion mutants of Brucella vaccine strain M5-90
Author:
Affiliation:

Fund Project:

Supported by the National Basic Research Program of China (973 Project) (2010CB30203), the Item of International Cooperative Science and Technology (2006DFA33740), the National Natural Science Foundation of China (30760187), and the National Natural Science Foundation of China (30800813)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:【目的】构建布鲁氏菌virB2基因缺失疫苗,弱化M5-90活苗的毒力。【方法】利用常规分子生物学技术构建同源重组自杀载体pGEM-7zf-ΔvirB2-sacB,电转化布鲁氏菌后分别经过氨苄抗性筛选和蔗糖敏感性筛选,对获得的基因缺失株进行PCR鉴定和稳定性检测。【结果】成功构建M5-90ΔvirB2基因缺失株,并且该缺失株在10代以内未发生回复突变。【结论】为研发新型布鲁氏菌弱毒基因缺失活苗奠定基础。

    Abstract:

    Abstract: [Objective] To construct Brucella vaccine strain M5-90ΔvirB2 deletion mutants with attenuated virulence. [Methods] We constructed the homologous recombination plasmid pGEM-7zf-ΔvirB2-sacB by using traditional molecular biology technology and then obtained M5-90ΔvirB2 strains by ampicillin and sucrose screens after electroporation. The deletion mutants were identified by PCR. Its stability were detected by continuous bacteria culture. [Results] The virB2 deletion mutant strains were successfully constructed. The reverse mutation did not occur within 10 passages. [Conclusion] The results of this study will based on the development of gene deletion attenuated vaccine of Brucella.

    参考文献
    相似文献
    引证文献
引用本文

李臻,张红星,唐利燕,陈创夫,王远志. 布鲁氏菌M5-90疫苗株virB2基因缺失株的构建及鉴定. 微生物学报, 2010, 50(12): 1677-1680

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2010-04-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码